awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40077487-AFCE0560-D12D-408C-BEE7-54CCB6B11D83
Q40077487-AFCE0560-D12D-408C-BEE7-54CCB6B11D83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40077487-AFCE0560-D12D-408C-BEE7-54CCB6B11D83
Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients.
P2860
Q40077487-AFCE0560-D12D-408C-BEE7-54CCB6B11D83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40077487-AFCE0560-D12D-408C-BEE7-54CCB6B11D83
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e5d957bca6790fa9ffbfe92426ca29ee73f645e1
P2860
Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.